Dominik Grzegorz Sokalski, M.D. Internal Medicine - Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 1365 Poplar Dr, Medford, OR 97504 Phone: 541-773-2233 Fax: 541-773-7089 |
Dr. David Lawrence Chamberland, MD Internal Medicine - Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 1365 Poplar Dr, Medford, OR 97504 Phone: 541-773-2233 |
Dr. Christine Konya, MD Internal Medicine - Rheumatology Medicare: Not Enrolled in Medicare Practice Location: 1365 Poplar Dr, Medford, OR 97504 Phone: 541-773-2233 Fax: 541-773-7089 |
Dr. Zhijie Zhou, MD Internal Medicine - Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 1365 Poplar Dr, Medford, OR 97504 Phone: 541-773-2233 Fax: 541-773-7089 |
News Archive
Mayo Clinic Employees Responded To New Requirements For Cost Sharing By Reducing Possibly Unneeded Health Services Use - Researchers at the Mayo Clinic examined the effects of changes in the clinic's self-funded health plan "to decrease the use of potentially inappropriate health care services and foster a deliver system centered on primary care."
In healthy volunteers, the equivalent of two cups of coffee reduced the body's ability to boost blood flow to the heart muscle in response to exercise, and the effect was stronger when the participants were in a chamber simulating high altitude, according to a new study in the Jan. 17, 2006, issue of the Journal of the American College of Cardiology.
Most youth living with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) have not been diagnosed, according to a new prevalence study from researchers at DePaul University and Ann & Robert H. Lurie Children's Hospital of Chicago, published by the journal Child & Youth Care Forum.
An international study of nearly 100 clinical trials that were stopped early due to positive treatment effects has found that many of those effects were exaggerated. The authors of the study — published in the current issue of the Journal of the American Medical Association — recommend that researchers resist pressures to end clinical trials early and continue trials for longer periods before even considering premature termination.
Melanoma in humans is on the rise, with one in 50 individuals likely to have the disease. By developing cell lines that grow readily in culture, Dartmouth investigators led by Constance Brinckerhoff, PhD have created a fast-track research tool that remains applicable to many scientists who use mouse melanoma as a model system.
› Verified 5 days ago